How to Buy Suraksha Diagnostic Ltd Shares?
You can easily buy the stocks/shares of Suraksha Diagnostic Ltd (SURAKSHA) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Suraksha Diagnostic Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of SURAKSHA as on 15th May 2025 is ₹294.89What is the return on Suraksha Diagnostic Ltd share?
The past returns of Suraksha Diagnostic Ltd (SURAKSHA) share are- Past 1 week: N/A
- Past 1 month: -93.76
- Past 3 months: 17.78
- Past 6 months: -20.37
- Past 1 year: -21.50
- Past 3 years: N/A
- Past 5 years: -21.50
What is the Dividend yield % on Suraksha Diagnostic Ltd share?
The current dividend yield of Suraksha Diagnostic Ltd (SURAKSHA) is N/AWhat is the Market Cap of Suraksha Diagnostic Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Suraksha Diagnostic Ltd (SURAKSHA) is ₹1703.65Cr as of 15th May 2025What is the 52 Week High and Low of Suraksha Diagnostic Ltd?
The 52-week high and low of Suraksha Diagnostic Ltd (SURAKSHA) is ₹449 and ₹231.What is the PE and PB ratio of Suraksha Diagnostic Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Suraksha Diagnostic Ltd are 53.52 and 9.51 respectively.Which sector does Suraksha Diagnostic Ltd belong to?
Suraksha Diagnostic Ltd (SURAKSHA) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.What are the peers or stocks similar to Suraksha Diagnostic Ltd?
The peers or stocks similar to Suraksha Diagnostic Ltd are: and many others.Can't decide whether or not to buy Suraksha Diagnostic Ltd?
Worry no more! Login to Tickertape and check out Suraksha Diagnostic Ltd (SURAKSHA) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Suraksha Diagnostic Ltd?
The 52-week high and low of Suraksha Diagnostic Ltd (SURAKSHA) is ₹449 and ₹231.1. Test Stocks FAQ for Suraksha Diagnostic Ltd Shares?
You can easily buy the stocks/shares of Suraksha Diagnostic Ltd (SURAKSHA) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Suraksha Diagnostic Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of SURAKSHA as on 15th May 2025 is ₹294.89
Suraksha Diagnostic Ltd
SURAKSHA Share Price
294.892.96% (-9.01)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SURAKSHA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SURAKSHA Performance & Key Metrics
SURAKSHA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 53.54 | 9.51 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.21 | 6.66 | 0.83% |
SURAKSHA Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SURAKSHA Company Profile
Suraksha Diagnostic Ltd operates diagnostic centers offering comprehensive pathology and radiology services, including imaging and medical consultations.
MAXHEALTH
PE Ratio
111.25
111.25
1Y Return
38.51%
38.51%
Buy Reco %
100.00
100.00
APOLLOHOSP
PE Ratio
69.46
69.46
1Y Return
12.70%
12.70%
Buy Reco %
100.00
100.00
FORTIS
PE Ratio
73.43
73.43
1Y Return
56.11%
56.11%
Buy Reco %
100.00
100.00
PE Ratio
49.11
49.11
1Y Return
55.97%
55.97%
Buy Reco %
87.50
87.50
MEDANTA
PE Ratio
66.10
66.10
1Y Return
7.16%
7.16%
Buy Reco %
—
—
SURAKSHA Sentiment Analysis
SURAKSHA Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
SURAKSHA Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
SURAKSHA Stock Growth Drivers
SURAKSHA Stock Growth Drivers
0
Hmm, looks like there are nogrowth drivers
SURAKSHA Stock Challenges
SURAKSHA Stock Challenges
1Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
SURAKSHA Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
SURAKSHA Forecasts
Price
Revenue
Earnings
SURAKSHA Share Price Forecast
SURAKSHA Share Price Forecast
2025
Current
₹327.55
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹327.55
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
SURAKSHA Company Revenue Forecast
SURAKSHA Company Revenue Forecast
2025
Current
₹255.94
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹255.94
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
SURAKSHA Stock EPS (Earnings Per Share) Forecast
SURAKSHA Stock EPS (Earnings Per Share) Forecast
2025
Current
₹5.97
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹5.97
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
SURAKSHA
SURAKSHA
Income
Balance Sheet
Cash Flow
Annual Normal View
SURAKSHA Income Statement
SURAKSHA Income Statement
Annual Normal View
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 159.04 | 141.39 | 225.49 | 193.68 | 222.26 | 255.94 | 255.94 | |||||||
Raw Materials | 21.34 | 26.01 | 60.40 | 27.40 | 27.25 | 170.85 | 170.86 | |||||||
| Power & Fuel Cost | 5.87 | 0.00 | 5.22 | 6.74 | 6.91 | |||||||||
| Employee Cost | 31.92 | 23.08 | 34.14 | 39.82 | 40.07 | |||||||||
| Selling & Administrative Expenses | 26.86 | 24.34 | 27.69 | 57.48 | 60.34 | |||||||||
| Operating & Other expenses | 37.41 | 43.96 | 47.65 | 14.26 | 14.03 | |||||||||
EBITDA | 35.64 | 24.00 | 50.39 | 47.98 | 73.66 | 85.09 | 85.08 | |||||||
| Depreciation/Amortization | 12.59 | 15.71 | 15.09 | 31.67 | 32.60 | 35.30 | 35.30 | |||||||
| PBIT | 23.05 | 8.29 | 35.30 | 16.31 | 41.06 | 49.79 | 49.78 | |||||||
| Interest & Other Items | 2.03 | 1.90 | 2.10 | 9.56 | 9.60 | 8.39 | 8.39 | |||||||
| PBT | 21.02 | 6.39 | 33.20 | 6.75 | 31.46 | 41.40 | 41.39 | |||||||
| Taxes & Other Items | 5.80 | -0.06 | 9.44 | 0.23 | 7.83 | 9.57 | 9.57 | |||||||
| Net Income | 15.22 | 6.45 | 23.76 | 6.52 | 23.63 | 31.83 | 31.82 | |||||||
| EPS | 17.65 | 7.48 | 27.55 | 7.56 | 27.40 | 5.97 | 36.89 | |||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SURAKSHA Company Updates
FY 2025FY 2025
Investor Presentation
May 29PDF
Feb 8PDF
SURAKSHA Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
SURAKSHA Past Performance & Peer Comparison
SURAKSHA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation-basic on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Suraksha Diagnostic Ltd | 53.52 | 9.51 | — |
| Max Healthcare Institute Ltd | 111.25 | 14.23 | 0.12% |
| Apollo Hospitals Enterprise Ltd | 69.46 | 13.72 | 0.40% |
| Fortis Healthcare Ltd | 73.43 | 6.64 | 0.13% |
SURAKSHA Stock Price Comparison
Compare SURAKSHA with any stock or ETFCompare SURAKSHA with any stock or ETF
SURAKSHA
SURAKSHA Holdings
SURAKSHA Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
SURAKSHA Promoter Holdings Trend
SURAKSHA Promoter Holdings Trend
SURAKSHA Institutional Holdings Trend
SURAKSHA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
SURAKSHA Shareholding Pattern
SURAKSHA Shareholding Pattern
SURAKSHA Shareholding History
SURAKSHA Shareholding History
Foreign Institutions
smallcases containing SURAKSHA stock
smallcases containing SURAKSHA stock
Looks like this stock is not in any smallcase yet.
SURAKSHA Events
SURAKSHA Events
SURAKSHA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SURAKSHA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
SURAKSHA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SURAKSHA has not given any dividends in last 5 years
SURAKSHA Dividends
SURAKSHA Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSURAKSHA Stock News & Opinions
SURAKSHA Stock News & Opinions
Articles & Videos
Corporate
Suraksha Diagnostic to conduct AGM
Suraksha Diagnostic announced that the 20th Annual General Meeting(AGM) of the company will be held on 5 September 2025.Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Earnings
Suraksha Diagnostic consolidated net profit rises 13.34% in the March 2025 quarter
Net profit of Suraksha Diagnostic rose 13.34% to Rs 7.39 crore in the quarter ended March 2025 as against Rs 6.52 crore during the previous quarter ended March 2024. Sales rose 17.94% to Rs 65.09 crore in the quarter ended March 2025 as against Rs 55.19 crore during the previous quarter ended March 2024. For the full year,net profit rose 34.66% to Rs 31.82 crore in the year ended March 2025 as against Rs 23.63 crore during the previous year ended March 2024. Sales rose 15.26% to Rs 252.09 crore in the year ended March 2025 as against Rs 218.71 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales65.0955.19 18 252.09218.71 15 OPM %29.4735.28 -32.2332.04 - PBDT17.9418.37 -2 76.7064.83 18 PBT9.2110.01 -8 41.4132.23 28 NP7.396.52 13 31.8223.63 35 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Earnings
Suraksha Diagnostic standalone net profit rises 17.11% in the March 2025 quarter
Net profit of Suraksha Diagnostic rose 17.11% to Rs 8.01 crore in the quarter ended March 2025 as against Rs 6.84 crore during the previous quarter ended March 2024. Sales rose 15.86% to Rs 64.15 crore in the quarter ended March 2025 as against Rs 55.37 crore during the previous quarter ended March 2024. For the full year,net profit rose 37.16% to Rs 33.44 crore in the year ended March 2025 as against Rs 24.38 crore during the previous year ended March 2024. Sales rose 13.99% to Rs 249.10 crore in the year ended March 2025 as against Rs 218.52 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales64.1555.37 16 249.10218.52 14 OPM %30.9035.99 -33.1632.58 - PBDT18.7018.86 -1 78.5966.05 19 PBT10.0410.53 -5 43.8633.48 31 NP8.016.84 17 33.4424.38 37 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Suraksha Diagnostic schedules board meeting
Suraksha Diagnostic will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Spotlight
Suraksha Diagnostic slips after CFO resigns
The company stated, Due to personal reasons, Amit Saraf, CFO and KMP of the company, has resigned from the services of the company w.e.f. 15.02.2025. The shares of Suraksha Diagnostic entered the stock market on 6 December 2024. The scrip was listed at Rs 437, exhibiting a discount of 0.91% to the issue price of Rs 441. Suraksha Diagnostic is a leading provider of integrated solutions in pathology and radiology testing, as well as medical consultation services, offering a seamless experience to customers through an extensive operational network. The company reported a 32.25% jump in consolidated net profit to Rs 6.15 crore in Q3 FY25, compared with Rs 4.65 crore in Q3 FY24. Revenue from operations increased 14.83% YoY to Rs 59.51 crore during the quarter ended 31 December 2024.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Suraksha Diagnostic consolidated net profit rises 32.26% in the December 2024 quarter
Net profit of Suraksha Diagnostic rose 32.26% to Rs 6.15 crore in the quarter ended December 2024 as against Rs 4.65 crore during the previous quarter ended December 2023. Sales rose 14.84% to Rs 59.51 crore in the quarter ended December 2024 as against Rs 51.82 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales59.5151.82 15 OPM %30.6829.54 - PBDT16.8714.14 19 PBT8.056.22 29 NP6.154.65 32 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Suraksha Diagnostic to table results
Suraksha Diagnostic will hold a meeting of the Board of Directors of the Company on 8 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Pledged promoter holdings is insignificant